Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies
A common strategy to target nanoparticles to tumours is conjugation with specific antibodies, targeting protein expressed preferentially by cancer cells. Here the authors show that the number of antibodies bound to the nanoparticle influences the targeting abilityin vitro and in vivo.
Guardado en:
Autores principales: | Miriam Colombo, Luisa Fiandra, Giulia Alessio, Serena Mazzucchelli, Manuela Nebuloni, Clara De Palma, Karsten Kantner, Beatriz Pelaz, Rany Rotem, Fabio Corsi, Wolfgang J. Parak, Davide Prosperi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31b037daafdb46eeb3c7cc68a126dbc7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Unexpected stability of aqueous dispersions of raspberry-like colloids
por: Yang Lan, et al.
Publicado: (2018) -
Burnout, Attachment and Mentalization in Nursing Students and Nurse Professionals
por: Giulia Bordoagni, et al.
Publicado: (2021) -
Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations
por: Salvioni L, et al.
Publicado: (2017) -
Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma
por: Juli R. Bagó, et al.
Publicado: (2016) -
Attachment & human development
Publicado: (1999)